PRINCETON, N.J., Sept. 17 /PRNewswire/ -- Ranbaxy Laboratories Ltd., today announced that they have retained the services of former New York City Mayor Rudy Giuliani and Giuliani Partners to provide advice and review compliance issues related to the recent United States Food and Drug Administration letters and Import Advisory.
In announcing the addition of Mayor Giuliani, Ranbaxy reiterated its commitment to work cooperatively with the FDA to address the Import Advisory and put into place measures which will allow its products identified on the Advisory to be released into the US marketplace.
As the FDA stated, all drugs manufactured by Ranbaxy have repeatedly tested safe and effective with no adverse incidents reported. Ranbaxy is committed to a swift resolution to address these issues and to continuing to supply the global marketplace with safe and effective pharmaceuticals.
Ranbaxy is one of the world's largest manufacturers of generic drugs, with production facilities in the United States and India.
Company Contacts for Media:
India Contact
Ramesh L. Adige
Executive Director-Corporate Affairs and Global Corporate Communications
Ranbaxy Laboratories Ltd.
Plot 90, Sector 32, Gurgaon
Haryana122001, India
Tel: +91-124-4135000
e-mail: ramesh.adige@ranbaxy.com
or
Raghu Kochar
Director-Corporate Communications
Ranbaxy Laboratories Ltd.
Plot 90, Sector 32, Gurgaon
Haryana122001, India
Tel: +91-124-4135141
Mobile: 9811617256
e-mail: raghu.kochar@ranbaxy.com
or
Krishnan Ramalingam
Sr.Manager-Corporate Communications
Plot 90, Sector 32, Gurgaon
Haryana122001, India
Tel: +91-124-4135143
Mobile: 9810042540
e-mail: krishnan.ramalingam@ranbaxy.com
USA Contact:
Charles M. Caprariello
Vice President, Corporate Communications.
Ranbaxy Inc.
600 College Road East
Princeton, NJ 08540
(609) 720-5615
CONTACT: India Contact, Ramesh L. Adige, Executive Director-Corporate
Affairs and Global Corporate Communications, +91-124-4135000,
ramesh.adige@ranbaxy.com, Raghu Kochar, Director-Corporate Communications,
+91-124-4135141, Mobile: 9811617256, raghu.kochar@ranbaxy.com, or Krishnan
Ramalingam, Sr.Manager-Corporate Communications, +91-124-4135143, Mobile:
9810042540, krishnan.ramalingam@ranbaxy.com, all of Ranbaxy Laboratories
Ltd., or USA Contact, Charles M. Caprariello, Vice President, Corporate
Communications of Ranbaxy Inc., +1-609-720-5615
